Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neratinib with Paclitaxel in HER2+ Breast Cancer
NCT01008150Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Oct 2010
- Primary completion
- Sep 2015
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of neratinib in breast cancer, sponsored by NSABP Foundation. Started Oct 2010; status: completed.
02
Drugs
neratinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01008150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008150.